VASCULAR SMOOTH-MUSCLE RELAXATION BY ALPHA-1-ADRENOCEPTOR BLOCKING ACTION OF DENOPAMINE IN ISOLATED RABBIT AORTA

被引:9
作者
AIKAWA, J
KOIKE, K
TAKAYANAGI, I
机构
[1] TOHO UNIV, SCH MED, DEPT INTERNAL MED 3, OHASHI 2-17-6, MEGURO KU, TOKYO 153, JAPAN
[2] TOHO UNIV, SCH PHARMACEUT SCI, DEPT CHEM PHARMACOL, CHIBA, JAPAN
关键词
DENOPAMINE; VASCULAR SMOOTH MUSCLE RELAXATION; ISOLATED RABBIT THORACIC AORTA; ALPHA-ADRENOCEPTOR BLOCKING ACTION; RECEPTOR BINDING ASSAY;
D O I
10.1097/00005344-199103000-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the mechanism of vascular relaxation by denopamine (Deno), an oral positive inotropic agent that has selective beta-1-adrenergic action. Deno relaxed, dose-dependently (0.1-30-mu-M), ring segments of rabbit aorta, which were partially precontracted with 1-mu-M phenylephrine (Phe) or norepinephrine (NE), but did not relax those precontracted with 5-mu-M prostaglandin F2-alpha or 40 mM K+. The relaxation was not significantly inhibited by pretreatment with 10-mu-M propranolol or metoprolol. Deno produced parallel shifts in concentration-response curves to Phe, but this was not true for clonidine. The Schild plot analysis resulted in a linear regression of a slope of 1.075 +/- 0.063, which was not significantly different from unity, and the pA2 value of Deno against Phe was 5.57 +/- 0.02. The specific binding of [H-3]prazosin to a rabbit aorta membrane preparation was displaced in a concentration-dependent manner by the simultaneous addition of Deno. The slope of a Hill plot was not significantly different from unity (1.102 +/- 0.147). The pK(I) value for Deno calculated from the displacement curve was 5.29 +/- 0.17, which was not significantly different from the pA2 value of Deno. In conclusion, vascular smooth muscle relaxation by Deno was mediated by the blocking effect of alpha-1-adrenoceptors. Thus, these findings suggest that Deno may be effective in the treatment of congestive heart failure because it elicits a positive inotropic effect by beta-1-adrenergic action and vasodilation by alpha-1-adrenergic blocking action.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 19 条
[1]  
ARIENS EJ, 1963, 1 P INT PHARM M, V7, P247
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]  
BING RJ, 1984, CURR THER RES CLIN E, V36, P1127
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   DIRECT MEASUREMENT OF VASCULAR ALPHA-1-ADRENOCEPTORS [J].
HOFFMAN, BB ;
TSUJIMOTO, G .
CLINICAL SCIENCE, 1985, 68 :S35-S37
[6]  
IKEO T, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1063
[7]   CARDIOVASCULAR EFFECTS AND PLASMA-LEVELS OF DENOPAMINE (TA-064), A NEW POSITIVE INOTROPIC AGENT, IN CHRONICALLY INSTRUMENTED DOGS [J].
IKEO, T ;
NAGAO, T ;
SUZUKI, T ;
YABANA, H ;
NAKAJIMA, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 39 (02) :191-199
[8]  
INAMASU M, 1987, BIOCHEM PHARMACOL, V36, P1947
[9]   CARDIOVASCULAR EFFECTS OF A NEWLY SYNTHESIZED CARDIOTONIC AGENT (TA-064) ON NORMAL AND DISEASED HEARTS [J].
KINO, M ;
HIROTA, Y ;
YAMAMOTO, S ;
SAWADA, K ;
MORIGUCHI, M ;
KOTAKA, M ;
KUBO, S ;
KAWAMURA, K .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (05) :802-810
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265